Literature DB >> 25891162

Resminostat: Opening the door to epigenetic treatments for liver cancer.

Jun Zhao1, Matthew W Lawless1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25891162     DOI： 10.1002/hep.27853

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  6 in total

1.  Comparison of percutaneous microwave ablation and laparoscopic resection in the prognosis of liver cancer.

Authors:  Juan Xu; Ye Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 2.  HDACs and HDAC Inhibitors in Cancer Development and Therapy.

Authors:  Yixuan Li; Edward Seto
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

Review 3.  Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.

Authors:  Jian-Jun Gao; Zhen-Yan Shi; Ju-Feng Xia; Yoshinori Inagaki; Wei Tang
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 4.  Modification of Epigenetic Histone Acetylation in Hepatocellular Carcinoma.

Authors:  Kwei-Yan Liu; Li-Ting Wang; Shih-Hsien Hsu
Journal:  Cancers (Basel)       Date:  2018-01-03       Impact factor: 6.639

5.  Anticancer effect of histone deacetylase inhibitor scriptaid as a single agent for hepatocellular carcinoma.

Authors:  Linlin Liu; Xiaoyang Sun; Yu Xie; Yinping Zhuang; Ruosi Yao; Kai Xu
Journal:  Biosci Rep       Date:  2018-07-12       Impact factor: 3.840

6.  In Vitro Compression Model for Orthodontic Tooth Movement Modulates Human Periodontal Ligament Fibroblast Proliferation, Apoptosis and Cell Cycle.

Authors:  Julia Brockhaus; Rogerio B Craveiro; Irma Azraq; Christian Niederau; Sarah K Schröder; Ralf Weiskirchen; Joachim Jankowski; Michael Wolf
Journal:  Biomolecules       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.